Apolipoprotein B
Showing 1 - 25 of >10,000
Familial Hypobetalipoproteinemia, Familial Hypobetalipoproteinemia - Heterozygous Form Trial (Administration of deuterated
Not yet recruiting
- Familial Hypobetalipoproteinemia
- Familial Hypobetalipoproteinemia - Heterozygous Form
- Administration of deuterated compounds for kinetic study
- (no location specified)
Oct 5, 2022
Familial Hypobetalipoproteinemia Trial in Nantes (Psychiatric population)
Completed
- Familial Hypobetalipoproteinemia
- Psychiatric population
-
Nantes, FranceNantes University Hospital Nantes
Sep 15, 2021
Dyslipidemia, Hypercholesterolemia Trial in Seoul (Test Meal)
Completed
- Dyslipidemia
- Hypercholesterolemia
- Test Meal
-
Seoul, Korea, Republic ofMSD Korea Ltd.
Feb 7, 2022
Cardiovascular Diseases Trial in New York (MEDI6012, Placebo)
Terminated
- Cardiovascular Diseases
- MEDI6012
- Placebo
-
New York, New YorkColumbia University Medical Center
Dec 10, 2020
Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,
Recruiting
- Hypercholesterolemia, Familial
- +25 more
- Genetic Testing
- +7 more
-
Moscow, Russian FederationNational Medical Research Centre for Therapy and Preventive Medi
Jul 25, 2022
Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial
Recruiting
- Familial Hypercholesterolemia
- +7 more
- Research-based genetic test for Familial Hypercholesterolemia
-
Vancouver, British Columbia, Canada
- +1 more
Jan 31, 2022
Obesity, Cardiovascular Disease Trial (Lifestyle-based physical activity)
Unknown status
- Obesity
- Cardiovascular Disease
- Lifestyle-based physical activity
- (no location specified)
Dec 30, 2019
Metabolic Syndrome Trial in Madrid (Experimental: Group 1: Spirulina platensis, Experimental: Group 2: Chlorella vulgaris,
Completed
- Metabolic Syndrome
- Experimental: Group 1: Spirulina platensis
- +2 more
-
Madrid, SpainInstitute for Health Research IdiPAZ
May 5, 2022
The Disease Severity In Patients With Psoriasis
Completed
- Psoriasis
-
Sukoharjo, Central Java, IndonesiaUniversitas Sebelas Maret Hospital
Jul 4, 2023
Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)
Recruiting
- Insulin Resistance
- +2 more
- Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 3, 2023
Morbid Obesity Trial in Pierre-Bénite (Low-fat dairy products, Whole-fat dairy products, Milk polar lipid enriched whole-fat
Not yet recruiting
- Morbid Obesity
- Low-fat dairy products
- +2 more
-
Pierre-Bénite, France
- +1 more
Mar 23, 2023
Hypercholesterolemia Trial in France, United States (Alirocumab, Placebo)
Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per
Recruiting
- Hyperinsulinemia
- +3 more
- Diazoxide oral suspension, 1 mg per kg per dose
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 6, 2023
Epidemiology of Genetic Factors in Lipid Metabolism
Completed
- Cardiovascular Diseases
- +2 more
- (no location specified)
Sep 29, 2021
Dyslipidemias, Non-Alcoholic Fatty Liver Disease Trial in San Antonio (LY3885125, Placebo)
Recruiting
- Dyslipidemias
- Non-Alcoholic Fatty Liver Disease
- LY3885125
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials, Early Phase Services LLC
Aug 18, 2023
Advanced Lipoproptein Profiling and Cardiovascular Risk
Recruiting
- Familial Hypercholesterolemia
- Atherosclerosis
- Additionnal blood samples
-
Paris, FranceHôpital de la Pitié Salpêtrière
Aug 2, 2022
Alzheimer 2 Due to Apoe4 Isoform Trial in Taipei (LI-40, MI-30, HI-16)
Completed
- Alzheimer Disease 2 Due to Apoe4 Isoform
- LI-40
- +2 more
-
Taipei, TaiwanDepartment of Physical Education and Sport Sciences, National Ta
Dec 6, 2022
Atherosclerotic Cardiovascular Disease in Brazilian Population
Recruiting
- Cardiovascular Diseases
- +4 more
- Exposure to genetics (polygenic)
-
Rio Branco, AC, Brazil
- +40 more
Aug 23, 2022
Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias Trial in Clermont-Ferrand (TOTUM-070)
Recruiting
- Hypercholesterolemia
- +4 more
- TOTUM-070
-
Clermont-Ferrand, FranceCIC Clermont Ferrand
Oct 25, 2022
Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a) Trial (SLN360, Placebo)
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- SLN360
- Placebo
- (no location specified)
Sep 12, 2022
Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)
Not yet recruiting
- Primary Hypercholesterolemia or Mixed Dyslipidemia
- Inclisiran
- Matching Placebo for Inclisiran
- (no location specified)
May 24, 2023
